Cita APA

Castaneda, C., Meadows, K. L., Truax, R., A, M., Morse, Kaufmann, S. H., . . . Hurwitz, H. I. (2011). Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors.

Citación estilo Chicago

Castaneda, Carlos, et al. Phase I and Pharmacokinetic Study of Lonafarnib, SCH 66336, Using a 2-week On, 2-week Off Schedule in Patients With Advanced Solid Tumors. 2011.

Cita MLA

Castaneda, Carlos, et al. Phase I and Pharmacokinetic Study of Lonafarnib, SCH 66336, Using a 2-week On, 2-week Off Schedule in Patients With Advanced Solid Tumors. 2011.